Abstract
Background. Treatment of prostate cancer involves androgen deprivation therapy with triptorelin. Despite oncological efficacy, the therapy causes adverse effects. Systemic complications of the therapy are well known, whereas changes in the upper respiratory tract, in particular the nasal mucosa, remain poorly studied by clinicians. This discrepancy between the widespread use of the drug and the lack of understanding of its impact on the respiratory epithelium dictates the need to search for safe correction. Purpose – is a systematic analysis of morphological and pathogenetic mechanisms of changes in the nasal mucosa under the conditions of testosterone-suppressing action of triptorelin and substantiation of the use of quercetin as a corrective agent. Materials and methods. Data from English-language literature obtained from scientometric databases Scopus Web of Science MEDLINE PubMed Google Scholar were studied and analyzed. The study covers mainly the last 5 years 2020-2025. A search by keywords systematic and comparative analysis of selected articles study of full-text articles for compliance with inclusion criteria in the reference list and relevance of the studies was conducted. Results. The nasal mucosa functions as an active hormone-dependent organ. Testosterone critically regulates mucociliary clearance by stimulating nitric oxide synthase expression providing vasodilation and antimicrobial protection. Chronic administration of triptorelin leads to receptor desensitization and reduction of testosterone concentration to castration level. Androgen deficiency transforms the mucosa reduction of nitric oxide correlates with dryness and congestion. Type 2 innate lymphoid cells physiologically suppressed by testosterone become activated secreting excess proinflammatory interleukins. This potentiates allergic inflammation, promoting the formation of a secretory aging epithelial phenotype. Tissue remodeling and the development of hormonal rhinitis require therapy. The bioflavonoid quercetin, due to its ability to mitigate oxidative stress and modulate inflammatory pathways without stimulating tumor growth, is considered an effective pathogenetic agent for the protection of the respiratory epithelium. Conclusions. The nasal mucosa is a hormone-sensitive target. Pharmacological castration with triptorelin disrupts nasal cavity homeostasis, causing inflammation and suppression of mucociliary clearance. The use of quercetin may represent a justified strategy for correcting nasal symptoms in oncological patients.

This publication has 51 references indexed in Scilit: